#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Follicular lymphoma stage I Measles Hypergammaglobulinaemia benign monoclonal Alternating hemiplegia of childhood Acute lymphocytic leukaemia recurrent Gastrointestinal neuroendocrine tumour Graft versus host disease Andersen-Tawil syndrome Synovitis Osteomyelitis Cluster headache Cutaneous T-cell lymphoma refractory Corneal neovascularisation Anti-neutrophil cytoplasmic antibody positive vasculitis Arrhythmogenic right ventricular dysplasia More trials…

    Learn about Rare Diseases

    Atypical haemolytic uraemic syndrome Antisynthetase syndrome – Diagnostics Myelodysplastic syndrome with excess blasts – Treatment Immunodeficiency congenital – Trials in Disease Proteus syndrome – Diagnostics Chondrosarcoma metastatic – Life with Disease Indolent systemic mastocytosis Shprintzen-Goldberg syndrome – Trials in Disease Testicular leiomyosarcoma Ornithine transcarbamoylase deficiency – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pf-06480605 Dexlansoprazole Human Coagulation Factor Vii Sitagliptin Sodium Fluoride (18F) Batoprotafib Plasma Avacopan Canis Familiaris (553) Sodium Iodide (123 I) D-Camphor Faricimab Domvanalimab Ceftriaxone Sodium Dexketoprofen Trometamol Phleum Pratense Pollen Extract PICLIDENOSON Mcla-129 Dextran 70 Digitoxin More therapies…

    Learn about Your Condition

    Perthes disease Stargardt's disease Asthma Hypereosinophilic syndrome Febrile neutropenia Primary biliary cholangitis Periarthritis Polyneuropathy Piriformis syndrome Biliary tract disorder Pulmonary hypertension Liposarcoma Epicondylitis Infantile spasms Diabetic foot infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effects of Autologous Bone Marrow-Derived Mononuclear Cells for Patients with Diabetic Foot Syndrome and Lower Limb Ischemia

    Recruiting

    4 1 1
    Investigated Diseases:
    • Diabetic foot
    • Peripheral arterial occlusive disease
    Investigated Drugs:
    • AUTOLOGOUS BONE MARROW-DERIVED MONONUCLEAR CELLS
    Czechia

  • Study on the Safety and Effectiveness of Allogenic Stem Cells for Treating Diabetic Foot Ulcers in Patients with Diabetes

    Recruiting

    2 1
    Poland

  • Study on Adding Zoledronic Acid to Standard Treatment for Patients with Glioblastoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Zoledronic Acid Monohydrate
    Latvia

  • Study on Revumenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy

    Recruiting

    3 1 1
    Investigated Drugs:
    • Azacitidine
    • Revumenib
    • Venetoclax
    Austria Belgium Denmark Estonia Finland France +8

  • Study on the Effectiveness and Safety of Efgartigimod IV for Adults with Primary Immune Thrombocytopenia

    Recruiting

    3 1 1
    Investigated Drugs:
    • Efgartigimod Alfa
    Austria Bulgaria Croatia Czechia France Germany +8

  • Study to Find the Right Dose and Safety of Lutetium (177Lu) Edotreotide and Arginine-Lysine in Children with Somatostatin Receptor-Positive Tumors

    Recruiting

    1 1 1
    Investigated Diseases:
    • Central nervous system neoplasm
    • Neuroendocrine tumour
    • Peripheral primitive neuroectodermal tumour of soft tissue
    Investigated Drugs:
    • L-Arginine Hydrochloride
    • L-Lysine Hydrochloride
    • Lutetium (177Lu) Edotreotide
    France Italy Spain
Previous Page
1 … 250 251 252 253 254 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!